FDA warns animal drug companies over unapproved antimicrobials, identifying “public health concerns”
In December 2023, the U.S. Food and Drug Administration (FDA) issued nine Warning Letters for the manufacture and distribution of unapproved over-the-counter (OTC) antimicrobial animal drugs for use ...
Today, the U.S. Food and Drug Administration conditionally approved Exzolt Cattle-CA1 (fluralaner) topical solution for the ...
Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. Prescription drugs indicated for use in veterinary medicine can be ...
The Food and Drug Administration is cautioning nine makers and distributors of drugs aimed at preventing infectious diseases in pets that their antimicrobial treatments could create resistance to ...
FDA Commissioner Martin Makary on Thursday announced a move away from animal-based drug testing in favor of human-based methods and artificial intelligence to determine drug safety and effectiveness.
PHOENIX — The Justice Department filed a complaint on Wednesday for a company in Gilbert that distributed adulterated and unapproved new animal drugs, authorities said. The complaint alleges that ...
The U.S. Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that there ...
Drugs have been tested on animals for over a century, but new technology may one day eliminate the need to do so. Congress and the FDA are pushing pharmaceutical companies to replace animals with ...
The way we test new medicines in the U.S. is about to change. The FDA is officially moving away from animal testing and embracing new technologies that rely on human cells and artificial intelligence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results